Neurocrine Biosciences, Inc. · NASDAQ:NBIX

Sherwin Stephen A sold 25,000 Neurocrine Biosciences, Inc. shares (Form 4)

Traded Jun 5, 2026 · Filed Jun 9, 2026

On Jun 5, 2026, Sherwin Stephen A (Director) sold 25,000 Neurocrine Biosciences, Inc. shares at an average US$165.32 for US$4.13M under a trading plan, leaving 15,860 shares. Filed Jun 9, 2026 (Form 4).

Sold
25,000 shares
Price
US$165.32 average (US$163.81 to US$167.31)
Value
US$4.13M
Holding after
15,860 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 5, 2026Common StockOption exercise15,000US$53.6430,860Direct
Jun 5, 2026Common StockOption exercise10,000US$79.7940,860Direct
Jun 5, 2026Common StockSale7,883US$163.8132,977Direct
Jun 5, 2026Common StockSale2,549US$164.4430,428Direct
Jun 5, 2026Common StockSale6,896US$165.7923,532Direct
Jun 5, 2026Common StockSale5,829US$166.5617,703Direct
Jun 5, 2026Common StockSale1,843US$167.3115,860Direct

Source

View original at SEC

Related